Local Institution - 0279 — Newark, Delaware

Local Institution - 0279 is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0279 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newark

Browse all research sites in Delaware · View every site in Newark

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0279?

Local Institution - 0279 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0279 conducted?

Local Institution - 0279 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Multiple Myeloma.

Is Local Institution - 0279 accredited by Crixeo Clinical Trials?

Local Institution - 0279 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0279?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.